KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsPayablesReal Estate - GrossReal Estate - NetReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Other Non-Current Assets (2016 - 2026)

Omega Healthcare Investors' Other Non-Current Assets history spans 18 years, with the latest figure at $27.2 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 24.76% to $27.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $27.2 million, a 24.76% decrease, with the full-year FY2025 number at $4.0 million, down 86.84% from a year prior.
  • Other Non-Current Assets hit $27.2 million in Q1 2026 for Omega Healthcare Investors, up from $4.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for OHI hit a ceiling of $250.6 million in Q3 2025 and a floor of $1.3 million in Q1 2024.
  • Historically, Other Non-Current Assets has averaged $36.2 million across 5 years, with a median of $4.0 million in 2025.
  • The widest YoY moves for Other Non-Current Assets: up 5416.1% in 2025, down 86.84% in 2025.
  • Tracing OHI's Other Non-Current Assets over 5 years: stood at $3.5 million in 2022, then plummeted by 45.78% to $1.9 million in 2023, then surged by 1483.07% to $30.4 million in 2024, then tumbled by 86.84% to $4.0 million in 2025, then skyrocketed by 579.3% to $27.2 million in 2026.
  • Business Quant data shows Other Non-Current Assets for OHI at $27.2 million in Q1 2026, $4.0 million in Q4 2025, and $250.6 million in Q3 2025.